{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Dobutamine vs Phenylephrine on Graft Flow in Cerebral Bypass Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This randomised crossover trial was conducted at the University Medical Centre Utrecht from September 2018 to July 2019."
      },
      "Participants": {
        "score": 2,
        "evidence": "Ten adult patients undergoing cerebral bypass surgery were included."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomly assigned to receive dobutamine to increase cardiac index or phenylephrine to increase mean arterial pressure (MAP)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess whether dobutamine administration results in greater graft perfusion than phenylephrine."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the absolute change in graft flow between the reference and intervention phases."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using sealed opaque envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "the anaesthesiologist was blinded to graft flow measurements."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Ten adult patients undergoing cerebral bypass surgery were included."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The analysis was conducted per-protocol."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Graft flow increased with a median of 4.1 ml/min (IQR, 1.7\u201312.0) after dobutamine and 3.6 ml/min (IQR, 1.3\u20137.8) after phenylephrine (difference \u20130.6 ml/min; 95% CI, \u201314.5 to 5.3; P = 0.441)."
      },
      "Harms": {
        "score": 1,
        "evidence": "One patient experienced a short episode of atrial arrhythmia during dobutamine administration, with no haemodynamic consequences."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The study was registered at the Netherlands Trial Register (NL7077)."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Departmental sources."
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}